Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 3T790M Positive NSCLC Patients 1Sexual Dysfunction, Physiological 1NSCLC 1Eunuchism 1Erectile Dysfunction 1EGF-R Positive Non-Small Cell Lung Cancer 1Brain Neoplasms 1

Interventions

osimertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × T790M Positive NSCLC Patients × osimertinib × Clear all
NCT03133234 2018-11-20

Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC

AstraZeneca

Completed
47 enrolled
Thoracic

T790M Positive NSCLC Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡